DCGI extends shelf life of Covishield from 6 to 9 months
Team Udayavani, Mar 31, 2021, 11:10 AM IST
New Delhi: India’s drug regulator DCGI has extended the shelf life of Covishield, the Oxford-AstraZeneca COVID-19 vaccine, from six to nine months from its manufacturing date.
In a letter to the Serum Institute of India, Drugs Controller General of India V G Somani said the SII is permitted to apply the shelf life of nine months to unlabelled vials available on hand.
Shelf life is the length of time for which an item remains fit for use.
The DCGI said it has no objection in respect of ‘Extension of Shelf Life of Covishield Vaccine’ in multi-dose glass vial (10 dose-5ml) from six months to nine months.
”You are permitted to apply the shelf life of nine months to unlabelled vials available on hand, subject to the condition that the details of such stock, batch-wise, shall be submitted to this office and Central Drugs Laboratory, Kasauli,” Somani said in the letter.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Nursing student suicide: Three students arrested in Kerala
Nadda’s letter to Kharge full of falsehoods: Cong
Mumbai terror accused Rana approaches US Supreme Court to challenge extradition to India
Who will be next Maharashtra CM? Mahayuti, MVA constituents drop different names
PM Modi leaves for home after concluding three-nation visit
MUST WATCH
Latest Additions
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.